A prominent example of the latter is ivacaftor, which acts as a potentiator of the cystic fibrosis transmembrane conductance regulator (CFTR), by increasing CFTR channel open probability in mutants associated with cystic fibrosis (Van Goor et al., 2009). This evidence concerns the gene CFTR and cystic fibrosis.